ArticleAnnals of hematology2023

Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.

Jia-Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.